SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
480Peter Meldrum: Your stock is again collared. Volume is relatively low, so it&#scaram(o)uche-11/22/2004
479b. Bona-fide Market Making We are adopting the proposed exception from the unifoscaram(o)uche-11/19/2004
478United States Patent Application 20040230035 Kind Code A1 Kahn, Michael ; scaram(o)uche-11/18/2004
477Nice capsule, thanks. Add Prolexys and a pipe that is reputed to be deep, well scaram(o)uche-11/16/2004
476Piper: MYGN :Strong Predictive Medicine Sales; Look For New INDs in CY2 Novemmopgcw-11/15/2004
475Nat Med. 2004 Oct;10(10):1065-6. Epub 2004 Sep 26. Nonsteroidal anti-inflammatscaram(o)uche-11/14/2004
474United States Patent Application 20040226056 Kind Code A1 Roch, Jean-Marc ;scaram(o)uche-11/11/2004
473drug discovery section of the Prolexys website has been updated......... prolexscaram(o)uche-11/11/2004
472newratings.com Myriad Genetics "market outperform," target price raisscaram(o)uche-11/10/2004
471Another decent quarter -- beats estimates by three cents -- so probably no more tuck-11/9/2004
470Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2005 Tuesday Nmopgcw-11/9/2004
469METHOD FOR TREATING NEURODEGENERATIVE DISORDERS Patent number: WO2004091522 Pubscaram(o)uche-11/7/2004
468But.... yeah, it was SIZE (anonymous interest, super montage) for the past twoscaram(o)uche-11/5/2004
467I'm not looking for that. After the last follow-on? They let it slip up, sscaram(o)uche-11/5/2004
466SIZE is still sitting at 17.90 and 18 with its nominal 100 shares. Are those thetom pope-11/5/2004
465Riddle: What biotech CEO makes David Robinson look sharp? (not talking haberdascaram(o)uche-11/5/2004
464Meldrum: Your silly "we will not partner, no matter the offer" stancescaram(o)uche-11/5/2004
463Anybody read this thread who lives in or around Salt Lake? Anybody interested escaram(o)uche-11/5/2004
462What's wrong with this picture?? Meldrum 2004.... salary, 521K, bonus, 24scaram(o)uche-11/5/2004
461Meldrum: It is a very rare thing to see sellers hurting a stock with intent, sescaram(o)uche-11/5/2004
460We again have "SIZE" (anonymous interest) on the ask at an even numberscaram(o)uche-11/4/2004
459Peter Meldrum: Please get new bankers. Thank you. Richard C. Harmon, Ph.D.scaram(o)uche-11/3/2004
458Myriad Genetics, Inc. Names Chief Operating Officer for Pharmaceuticals Tuesday scaram(o)uche-11/2/2004
457stuff just for parking, not even worth reading. just for future reference......scaram(o)uche-10/30/2004
456United States Patent Application 20040214255 Kind Code A1 Heichman, Karen ;scaram(o)uche-10/28/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News